Scientific Publications

A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors

20 March 2024

LEARN MORE

Inhibition of the Phosphatidylinositol-3 Kinase Pathway Using Bimiralisib in Loss-of-Function NOTCH1-Mutant Head and Neck Cancer

15 December 2022

LEARN MORE

Selected Scientific Publications based on our PQR620 compound

29 August 2022

LEARN MORE

Selected Scientific Publications based on our PQR309 compound

29 August 2022

LEARN MORE